AGO2 and Burkitt lymphoma: Furthermore, TargetScan-predicted miR-26b-5p targets were significantly enriched in the Ago2-IP fractions upon miR-26b overexpression, as compared to the Ago2-IP fractions of pCDH-EV in both BL cell lines (Figure 3B).